Show simple item record

[beta]-Endorphin suppression of acute morphine abstinence in morphine dependent monkeys: Effective given intraventricularly but ineffective given intravenously

dc.contributor.authorDomino, Edward F.en_US
dc.contributor.authorLi, Choh Haoen_US
dc.date.accessioned2006-04-07T19:03:33Z
dc.date.available2006-04-07T19:03:33Z
dc.date.issued1985-07en_US
dc.identifier.citationDomino, Edward F., Li, Choh Hao (1985/07)."[beta]-Endorphin suppression of acute morphine abstinence in morphine dependent monkeys: Effective given intraventricularly but ineffective given intravenously." Neuropeptides 6(4): 343-350. <http://hdl.handle.net/2027.42/25633>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6WNR-4C48BVG-1F/2/bcc87b32f9e8bf3d2ba96889ed8370e8en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/25633
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2931615&dopt=citationen_US
dc.description.abstractSix female adult monkeys were made dependent upon morphine sulfate and were implanted with a chronic indwelling needle in the lateral ventricle of the brain for sterile intraventricular injections. Both [beta]-endorphin and morphine, in a dose dependent manner given intraventricularly suppressed the signs of 14 hour acute morphine abstinence. On a molar basis, [beta]-endorphin was more active than morphine in suppressing the signs of morphine abstinence. When given intravenously in much larger doses, [beta]-endorphin was ineffective in contrast to morphine which was effective in suppressing abstinence.en_US
dc.format.extent462980 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.title[beta]-Endorphin suppression of acute morphine abstinence in morphine dependent monkeys: Effective given intraventricularly but ineffective given intravenouslyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelChemical Engineeringen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelEngineeringen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationotherLaboratory of Molecular Endocrinology, University of California, San Francisco, CA 94143, USAen_US
dc.identifier.pmid2931615en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/25633/1/0000183.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0143-4179(85)90007-1en_US
dc.identifier.sourceNeuropeptidesen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.